October 4, 2016
EA Pharma and Mochida Pharmaceutical said on September 30 that elobixibat (development code: AJG533), a chronic constipation drug being jointly developed in Japan, met the primary endpoint in a Japan PIII study. They hope to file the drug in the...read more